Literature DB >> 8383325

Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans.

J A Corbett1, M A Sweetland, J L Wang, J R Lancaster, M L McDaniel.   

Abstract

Cytokines have been implicated as immunological effector molecules that mediate beta cell destruction associated with insulin-dependent diabetes mellitus. In this report we demonstrate that the cytokine combination of human recombinant interleukin 1 beta (IL-1 beta), tumor necrosis factor alpha (TNF-alpha), and interferon gamma (IFN-gamma) induces the formation of nitric oxide by human islets. This combination of cytokines stimulates both the formation of the nitric oxide derivative, nitrite, and the accumulation of cGMP by human islets. The nitric oxide synthase inhibitor NG-monomethyl-L-arginine prevents formation of both cGMP and nitrite. IL-1 beta and IFN-gamma are sufficient to induce nitric oxide formation by human islets, whereas TNF-alpha potentiates nitrite production. This combination of cytokines (IL-1 beta, TNF-alpha, and IFN-gamma) also influences insulin secretion by human islets. Pretreatment of human islets with low concentrations of this cytokine combination (IL-1 beta at 15 units/ml, 0.7 nM TNF-alpha, and IFN-gamma at 150 units/ml) appears to slightly stimulate insulin secretion. Higher concentrations (IL-1 beta at 75 units/ml, 3.5 nM TNF-alpha, and IFN-gamma at 750 units/ml) inhibit insulin secretion from human islets, and the inhibitory effect is prevented by NG-monomethyl-L-arginine. This higher concentration of cytokines also induces the formation of an electron paramagnetic resonance-detectable g = 2.04 axial feature by human islets that is characteristic of the formation of an iron-dithio-dinitrosyl complex. The formation of this complex is prevented by NG-monomethyl-L-arginine, thus confirming that this cytokine combination induces the formation of nitric oxide by human islets. These results indicate that nitric oxide mediates the inhibitory effects of cytokines on glucose-stimulated insulin secretion by human islets and suggest that nitric oxide may participate in beta-cell dysfunction associated with insulin-dependent diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383325      PMCID: PMC45953          DOI: 10.1073/pnas.90.5.1731

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans.

Authors:  K Bendtzen; T Mandrup-Poulsen; J Nerup; J H Nielsen; C A Dinarello; M Svenson
Journal:  Science       Date:  1986-06-20       Impact factor: 47.728

2.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

3.  Interleukin 1 dose-dependently affects the biosynthesis of (pro)insulin in isolated rat islets of Langerhans.

Authors:  G A Spinas; B S Hansen; S Linde; W Kastern; J Mølvig; T Mandrup-Poulsen; C A Dinarello; J H Nielsen; J Nerup
Journal:  Diabetologia       Date:  1987-07       Impact factor: 10.122

4.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

Authors:  L C Green; D A Wagner; J Glogowski; P L Skipper; J S Wishnok; S R Tannenbaum
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

5.  Low-temperature culture of human islets isolated by the distention method and purified with Ficoll or Percoll gradients.

Authors:  D W Scharp; P E Lacy; E Finke; B Olack
Journal:  Surgery       Date:  1987-11       Impact factor: 3.982

6.  Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation.

Authors:  K D Kröncke; V Kolb-Bachofen; B Berschick; V Burkart; H Kolb
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

7.  Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy.

Authors:  J B Hibbs; C Westenfelder; R Taintor; Z Vavrin; C Kablitz; R L Baranowski; J H Ward; R L Menlove; M P McMurry; J P Kushner
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

8.  Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice.

Authors:  L S Wicker; B J Miller; Y Mullen
Journal:  Diabetes       Date:  1986-08       Impact factor: 9.461

9.  Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans.

Authors:  P G Comens; B A Wolf; E R Unanue; P E Lacy; M L McDaniel
Journal:  Diabetes       Date:  1987-08       Impact factor: 9.461

10.  Adoptive transfer of autoimmune diabetes mellitus in biobreeding/Worcester (BB/W) inbred and hybrid rats.

Authors:  A A Like; E J Weringer; A Holdash; P McGill; D Atkinson; A A Rossini
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

View more
  108 in total

1.  Cytokines activate genes of the endocytotic pathway in insulin-producing RINm5F cells.

Authors:  K L A Souza; M Elsner; P C F Mathias; S Lenzen; M Tiedge
Journal:  Diabetologia       Date:  2004-07-10       Impact factor: 10.122

Review 2.  Advancing islet transplantation: from engraftment to the immune response.

Authors:  R F Gibly; J G Graham; X Luo; W L Lowe; B J Hering; L D Shea
Journal:  Diabetologia       Date:  2011-08-10       Impact factor: 10.122

3.  The Role of Metabolic Flexibility in the Regulation of the DNA Damage Response by Nitric Oxide.

Authors:  Bryndon J Oleson; Katarzyna A Broniowska; Chay Teng Yeo; Michael Flancher; Aaron Naatz; Neil Hogg; Vera L Tarakanova; John A Corbett
Journal:  Mol Cell Biol       Date:  2019-08-27       Impact factor: 4.272

4.  Cytokine-mediated β-cell damage in PARP-1-deficient islets.

Authors:  Teresa Andreone; Gordon P Meares; Katherine J Hughes; Polly A Hansen; John A Corbett
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-04-24       Impact factor: 4.310

Review 5.  S-Nitrosothiol biology and therapeutic potential in metabolic disease.

Authors:  Christopher G Kevil; Rakesh P Patel
Journal:  Curr Opin Investig Drugs       Date:  2010-10

6.  Coexpression of vascular endothelial growth factor and interleukin-1 receptor antagonist for improved human islet survival and function.

Authors:  Xiangxu Jia; Kun Cheng; Ram I Mahato
Journal:  Mol Pharm       Date:  2007-01-26       Impact factor: 4.939

7.  Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.

Authors:  Kathrin Maedler; Pavel Sergeev; Frédéric Ris; José Oberholzer; Helen I Joller-Jemelka; Giatgen A Spinas; Nurit Kaiser; Philippe A Halban; Marc Y Donath
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

8.  Differential responses of pancreatic β-cells to ROS and RNS.

Authors:  Gordon P Meares; Dominique Fontanilla; Katarzyna A Broniowska; Teresa Andreone; Jack R Lancaster; John A Corbett
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-01-15       Impact factor: 4.310

9.  The involvement of endogenous nitric oxide in vagal-cholinergic stimulation of exocrine and endocrine pancreas in dogs.

Authors:  J Bilski; J W Konturek; S J Konturek; W Domschke
Journal:  Int J Pancreatol       Date:  1995-08

Review 10.  Aspects of novel sites of regulation of the insulin stimulus-secretion coupling in normal and diabetic pancreatic islets.

Authors:  A Sjöholm
Journal:  Endocrine       Date:  1998-08       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.